Takeda to Acquire Maverick for ~$525M

March 10, 2021 Auto Bot Acquire, Exclusive, M&A, Takeda 0

Shots:

  • Takeda exercised its option to acquire Maverick for up to $525M up front as well as development and regulatory milestones including Takeda’s current equity stake and Maverick debt. The acquisition is expected to finalize in Q1’21
  • The acquisition will expand Takeda’s I-O portfolio with the addition of two development candidates (MVC-101 & MVC-280) and Maverick’s T-cell engagers COBRA platform, specifically designed to target solid tumor
  • The acquisition 2017 collaboration of the companies to develop conditionally active T-cell engager therapies, in which Takeda received an equity stake and an exclusive right to acquire Maverick after 5yrs.

Click here ­to­ read full press release/ article | Ref: Takeda | Image: Maverick

The post Takeda to Acquire Maverick for ~$525M first appeared on PharmaShots.